Vertex Pharma (VRTX) Misses Q4 EPS by 8c, Revenues Beat; Provides FY21 Product Revenue Outlook
Go back to Vertex Pharma (VRTX) Misses Q4 EPS by 8c, Revenues Beat; Provides FY21 Product Revenue Outlook| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 505.75 -10.69 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $516.44 | 52 Week High | $134.71 | |||
| Open | $511.41 | 52 Week Low | $73.31 | |||
| Day High | $513.64 | P/E | N/A | |||
| Day Low | $502.29 | EPS | $-1.98 | |||
| Volume | 1,130,489 | |||||
